GenSight appoints new COO
This article was originally published in Scrip
Executive Summary
Paris, France-based GenSight Biologics, which develops gene-based therapies to preserve or restore vision in people with degenerative retinal and inherited ophthalmologic diseases, has named Dr Jean-Philippe Combal chief operating officer. Dr Combal will lead the company's operational activities and the development of its products. Prior to joining GenSight, he was leading development of early stage dermatological products – up to Phase IIb – at Galderma International.